Who Are We?

A Trusted Partner

Located in Boucherville, Québec, Sandoz Canada and its 800 employees are part of Sandoz International GmbH, the second-largest generics manufacturer worldwide and a subsidiary of the Swiss multinational company Novartis. A leader in its field, Sandoz Canada develops, manufactures, markets and distributes a broad range of generic products in numerous forms for both the retail pharmaceutical sector and the hospital sector.

A Name that’s Making its Mark

With more than 225 molecules, Sandoz has one of the largest product ranges in Canada. The company continues to demonstrate its leadership each year by expanding its range of products with the development of innovative new oral and injectable generics and complex medications such as controlled-release drugs and subsequent entry biologics.

Sandoz Canada is also a worldwide centre of excellence for the development of injectable products within the Sandoz Group. Dynamic and creative, the company has one of the highest growth rates among the largest manufacturers of generic pharmaceutical products in the country. Between 2007 and 2009, the company invested nearly $100 million in its facilities, built a new head office and created more than 200 new jobs.

Balance is the Source of our Success

In addition to its leadership, Sandoz Canada stands out for its balance. The balance between the expansion of an international organization and an in-depth knowledge of the local healthcare environment and the needs of the community. The balance between a portfolio of effective and affordable generic products and Sandoz’s role as a pioneer in the cutting-edge science of subsequent entry biologics. The balance between the necessary drive for continuous improvement and the importance that the company places on customers and reliable service.

Sandoz International GmbH: A World of Difference

Sandoz, a division of Novartis, is a world leader in the generics sector. With a presence in over 130 countries, Sandoz enables patients worldwide to have access to high-quality, affordable medications and contributes to the stabilization of healthcare costs.

The Sandoz portfolio includes more than 1,000 molecules. Sandoz specializes in the development and marketing of anti-infective agents and differentiated medications such as controlled-release products and subsequent entry biologics, which gives it a unique competitive advantage.

In 2011, Sandoz had more than 23,000 employees and sales of US$9.5 billion.